An interview with Leslie Trigg, President and CEO of Outset Medical


A new CMS regulation that would potentially curtail third party payments for insurance for dialysis patients has been delayed by a U.S. District Court judge in Texas.

Medical care in the United States is poised to undergo one of the most comprehensive transformations in the past 50 years, prodded by ever-rising costs and poor population health performance. To address these and other challenges, Congress—with support from President Barack Obama—passed the Medicare Access and CHIP Reauthorization Act (MACRA) in 2015.

Kidney care in the United States is undergoing a rapid transformation as the primary payer, Medicare, moves from volume-based, fee-for-service payment systems to value-based payment systems. Nearly 50% of current CMS payments are based on value delivered, and by 2020 this is likely to be over 90%.

Infections are now neck and neck with cardiovascular complications as a primary reason for hospitalization and mortality among kidney patients receiving dialysis.

Endorsing a more diverse, inclusive, and global society, 93% of ASN Active Members recently approved the first revision of the society’s bylaws since 2006.